Process for forming a direct positive image
    12.
    发明授权
    Process for forming a direct positive image 失效
    形成直接正像的过程

    公开(公告)号:US4835091A

    公开(公告)日:1989-05-30

    申请号:US65353

    申请日:1987-06-23

    IPC分类号: G03C1/485 G03C7/30 G03C7/407

    摘要: A process for forming a direct positive image which comprises image-wise exposing a light-sensitive material comprising a support having provided thereon at least one internal latent image type direct positive silver halide photographic emulsion layer, subjecting the selecting material to whole surface exposure before or during developing process, and then developing the resulting material in the presence of a quaternary salt type nucleating agent or a hydrazine type nucleating agent.The process is very high in the latitude for changes of expose amount, developing time, developing solution components, process temperature and the like and makes it possible to progress the development is a short time even in a low pH developing solution.

    摘要翻译: 一种用于形成直接正像的方法,该方法包括使包含具有至少一个内部潜像型直接正卤化银摄影乳剂层的支持体的感光材料成像曝光,使选择材料经受整个表面曝光之前或 在显影过程中,然后在季盐型成核剂或肼型成核剂的存在下显影所得材料。 该过程在曝光量,显影时间,显影液成分,加工温度等的变化的纬度上是非常高的,并且即使在低pH显影液中也可以进行短时间的发展。

    Direct positive photographic material
    13.
    发明授权
    Direct positive photographic material 失效
    直接正面摄影材料

    公开(公告)号:US5009993A

    公开(公告)日:1991-04-23

    申请号:US422268

    申请日:1989-10-16

    IPC分类号: G03C1/485

    CPC分类号: G03C1/48538 Y10S430/141

    摘要: A direct positive photographic material comprising a support having provided thereon one or more hydrophilic colloid containing layers, wherein at least one of said hydrophilic colloid containing layers is an internal latent image type silver halide emulsion which has not been previously fogged and at least one of said emulsion layer or other hydrophilic colloid containing layer contains a colloidal metal or a colloidal water-insoluble metallic sulfide, selenide or telluride, and a method for forming a direct positive from the direct positive photographic material in which a light-sensitive material contains at least two layers containing colloidal silver.

    Direct positive photographic material
    14.
    发明授权
    Direct positive photographic material 失效
    直接正面摄影材料

    公开(公告)号:US4880727A

    公开(公告)日:1989-11-14

    申请号:US101693

    申请日:1987-09-28

    IPC分类号: G03C1/485

    CPC分类号: G03C1/48538 Y10S430/141

    摘要: A direct positive photographic material comprising a support having provided thereon one or more hydrophilic colloid containing layers, wherein at least one of said hydrophilic colloid containing layers is an internal latent image type silver halide emulsion which has not been previously fogged and at least one of said emulsion layer or other hydrophilic colloid containing layer contains a colloidal metal or a colloidal water-insoluble metallic sulfide, selenide or telluride, and a method for forming a direct positive from the direct positive photographic material in which a light-sensitive material contains at least two layers containing colloidal silver.

    摘要翻译: 一种直接正性照相材料,其包括在其上设置有一种或多种含亲水胶体的层的载体,其中至少一种所述含亲水胶体的层是未被雾化的内部潜像型卤化银乳剂,并且所述至少一种所述 乳液层或其它含亲水胶体层含有胶态金属或胶态水不溶性金属硫化物,硒化物或碲化物,以及从直接正性照相材料形成直接阳性的方法,其中感光材料含有至少两种 含有胶体银的层。

    Silver halide photographic material comprising a specified nucleating
agent
    15.
    发明授权
    Silver halide photographic material comprising a specified nucleating agent 失效
    包含特定成核剂的卤化银照相材料

    公开(公告)号:US4877723A

    公开(公告)日:1989-10-31

    申请号:US117725

    申请日:1987-11-06

    IPC分类号: G03C1/06 G03C1/485

    CPC分类号: G03C1/48546 Y10S430/141

    摘要: A silver halide photographic material which comprises a support having provided thereon at least one photosensitive silver halide photographic emulsion layer, wherein the emulsion layer or at least one of the other hydrophilic colloid layers contains at least one of alkynyl-substituted heterocyclic quaternary ammonium salts represented by the formula: ##STR1## wherein Z represents a group of non-metallic atoms required to form a 5- to 6-membered heterocyclic ring, R.sup.1 represents an aliphatic group, R.sup.2, R.sup.3 and R.sup.4, which may be the same or different, each represents a hydrogen atom, an aliphatic group, or an aromatic group, at least one of R.sup.1, R.sup.2, R.sup.3, R.sup.4 and Z has at least one substituent having an alkynyl group, Y represents a counter ion for the charge balance, and n is a number required for charge balance.

    摘要翻译: 一种卤化银照相材料,其包括其上提供有至少一个光敏卤化银照相乳剂层的载体,其中所述乳剂层或其它亲水胶体层中的至少一个包含至少一种炔基取代的杂环季铵盐 式(I)其中Z表示形成5-至6-元杂环所需的一组非金属原子,R 1表示脂族基团,R 2,R 3和R 4可以相同或不同, 不同的是,各自表示氢原子,脂族基团或芳香族基团,R 1,R 2,R 3,R 4和Z中的至少一个具有至少一个具有炔基的取代基,Y表示电荷平衡的抗衡离子, n是电荷平衡所需的数字。

    Direct positive color light-sensitive material comprising a DIR coupler
and a pyrazoloazole coupler, and a process for forming a direct
positive image
    16.
    发明授权
    Direct positive color light-sensitive material comprising a DIR coupler and a pyrazoloazole coupler, and a process for forming a direct positive image 失效
    包含DIR成色剂和吡唑并唑成色剂的直接正色感光材料以及形成直接正像的方法

    公开(公告)号:US4801520A

    公开(公告)日:1989-01-31

    申请号:US75008

    申请日:1987-07-17

    摘要: A direct positive color light-sensitive material comprising a support having provided thereon at least one photographic emulsion layer containing unfogged internal latent image type silver halide particles and a color image forming coupler, wherein said color image forming coupler itself is substantially nondiffusible and produces or releases a dye upon oxidation coupling with a color developing agent, and said light-sensitive material contains at least one development inhibitor-releasing type coupler selected from the group consisting of compounds represented by formulae (D-I) and (D-II)Coup--Z (D-I)Coup--TIME--Z (D-II)wherein Coup represents a coupler residual group; Z represents a diffusible development inhibitor or a precursor thereof; and TIME represents a timing group.

    摘要翻译: 一种直接正色感光材料,其包括在其上设置有至少一个含有未雾化的内部潜像型卤化银颗粒的摄影乳剂层和彩色图像形成耦合器的支撑体,其中所述彩色图像形成耦合器本身基本上是不可扩散的并且产生或释放 染料与彩色显影剂氧化偶联,所述光敏材料含有至少一种显影抑制剂释放型成色剂,其选自式(DI)和(D-II)Coup-Z( DI)Coup-TIME-Z(D-II)其中Coup表示成色剂残基; Z表示扩散性显影抑制剂或其前体; 而TIME表示时序组。

    Method of forming color images
    17.
    发明授权
    Method of forming color images 失效
    形成彩色图像的方法

    公开(公告)号:US5128238A

    公开(公告)日:1992-07-07

    申请号:US519341

    申请日:1990-05-03

    IPC分类号: G03C1/485 G03C7/30 G03C7/407

    摘要: A method for producing color images comprising developing a negative silver halide color photographic materials and an internal latent-image type direct positive silver halide color photogaphic material, with the same developer having a pH of 9.0 to 11.5, said direct positive photographic material containing at least one compound represented by formula (N-I) as nucleating agent and at least one compound represented by (I) or (II) as magenta coupler, thereby ensuring high color reproducibility to both photographic materials: ##STR1## wherein the symbols and substituents of said formulae are as defined in the specification.

    摘要翻译: 一种生产彩色图像的方法,包括显影负卤化银彩色照相材料和内部潜像型直接正卤化银彩色光影材料,其中pH为9.0至11.5的相同显影剂,所述直接正性照相材料至少含有 一种由式(NI)表示的化合物作为成核剂和至少一种由(I)或(II)表示的化合物作为品红色偶联剂,从而确保两种照相材料的高色彩再现性:(NI) (II)其中所述式的符号和取代基如说明书中所定义。

    NOVEL CONDENSED PYRIDINE OR CONDENSED PYRIMIDINE DERIVATIVE, AND MEDICINAL AGENT COMPRISING SAME
    18.
    发明申请
    NOVEL CONDENSED PYRIDINE OR CONDENSED PYRIMIDINE DERIVATIVE, AND MEDICINAL AGENT COMPRISING SAME 有权
    新型浓缩的吡啶或稠合的吡啶衍生物,以及包含其的药物

    公开(公告)号:US20130102621A1

    公开(公告)日:2013-04-25

    申请号:US13806940

    申请日:2011-06-24

    摘要: The present invention relates to provision of a novel compound that has an activity of promoting insulin secretion from pancreatic β cells and thus is useful as a prophylaxis and/or therapeutic agent for diseases caused by hyperglycemia such as diabetes mellitus, andthe compound represented by the following formula (1): wherein one of A and B represents a nitrogen atom and the other represents a nitrogen atom or CR10, X represents an oxygen atom, a sulfur atom or —(CH2)n-N(R12)—, Y represents an oxygen atom, a sulfur atom or —N(R13)—, and R1 to R9 each represent a hydrogen atom or another substituent, or a salt thereof, or a solvate of the compound or the salt.

    摘要翻译: 本发明涉及提供具有促进胰β细胞胰岛素分泌的活性的新型化合物,因此可用作由高血糖引起的疾病如糖尿病的预防和/或治疗剂,以及由 下式(1):其中A和B之一表示氮原子,另一个表示氮原子或CR 10,X表示氧原子,硫原子或 - (CH 2)n N(R 12) - ,Y表示氧 原子,硫原子或-N(R 13) - ,并且R 1至R 9各自表示氢原子或其它取代基,或其盐,或化合物或其盐的溶剂合物。

    Electric motor control apparatus
    19.
    发明授权
    Electric motor control apparatus 有权
    电动机控制装置

    公开(公告)号:US07990093B2

    公开(公告)日:2011-08-02

    申请号:US12279859

    申请日:2006-04-20

    IPC分类号: H02P7/00

    摘要: A control apparatus for a multiphase AC electric motor having an inverter includes a current control including an abnormal-state current controller; an abnormal-state detector that detects an abnormal state of any of a wire of an electric motor, a wire of an inverter, and a wire connecting the electric motor to the inverter as an abnormal phase; and an abnormal phase disconnect. The abnormal phase disconnect disconnects one or more of phases detected to be in an abnormal-state and the abnormal-state current controller generates an abnormal state voltage command in accordance with detection of an abnormal state, and uses phases other than the disconnected phases of the inverter to control individual currents of the phases, with the abnormal-state voltage command used as a multiphase voltage command.

    摘要翻译: 一种具有逆变器的多相交流电动机的控制装置包括:电流控制装置,包括异常电流控制器; 异常状态检测器,其检测电动机的线材,逆变器的线以及将电动机与逆变器连接的线的异常状态,作为异常相位; 和异常相断开。 异常相位断开断开检测到异常状态的一个或多个相位,异常状态电流控制器根据异常状态的检测产生异常状态电压指令,并且使用除 逆变器用于控制各相电流,异常状态电压指令用作多相电压指令。

    PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR HYPERLIPIDEMIA
    20.
    发明申请
    PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR HYPERLIPIDEMIA 有权
    高效药物和/或治疗药物

    公开(公告)号:US20100069433A1

    公开(公告)日:2010-03-18

    申请号:US12593356

    申请日:2008-03-28

    IPC分类号: A61K31/47 A61K31/42

    摘要: The present invention provides a therapeutic agent for hyperlipidemia having an excellent effect of lowering the cholesterol and triglyceride level in blood plasma.The present invention relates to a prophylactic and/or therapeutic agent for hyperlipidemia, a prophylactic and/or therapeutic agent for obesity or diabetes mellitus, and a prophylactic and/or therapeutic agent for metabolic syndrome, each agent including a compound represented by the following formula (1): , wherein: R1 and R2, which may be identical or different, each represent a hydrogen atom, a methyl group or an ethyl group; R3a, R3b, R4a and R4b, which may be identical or different, each represent a hydrogen atom, a halogen atom, a nitro group, a hydroxyl group, a C1-4 alkyl group, a trifluoromethyl group, a C1-4 alkoxy group, a C1-4 alkylcarbonyloxy group, a di-C1-4 alkylamino group, a C1-4 alkylsulfonyloxy group, a C1-4 alkylsulfonyl group, a C1-4 alkylsulfinyl group, or a C1-4 alkylthio group, or R3a and R3b, or R4a and R4b are joined to represent an alkylenedioxy group; X represents an oxygen atom, a sulfur atom or N—R5 (wherein R5 represents a hydrogen atom, a C1-4 alkyl group, a C1-4 alkylsulfonyl group, or a C1-4 alkyloxycarbonyl group); Y represents an oxygen atom, a S(O)l group (l represents a number from 0 to 2), a carbonyl group, a carbonylamino group, an aminocarbonyl group, a sulfonylamino group, an aminosulfonyl group, or an NH group; Z represents CH or N; n represents a number from 1 to 6; and m represents a number from 2 to 6, or a salt thereof, and a statin, particularly pitavastatin, in combination.

    摘要翻译: 本发明提供了具有降低血浆中胆固醇和甘油三酯水平的优异效果的高脂血症治疗剂。 本发明涉及高脂血症的预防和/或治疗剂,肥胖症或糖尿病的预防和/或治疗剂,以及代谢综合征的预防和/或治疗剂,每种试剂包括由下式表示的化合物 (1)表示:其中:R 1和R 2可以相同或不同,各自表示氢原子,甲基或乙基; R3a,R3b,R4a和R4b可以相同或不同,分别表示氢原子,卤素原子,硝基,羟基,C1-4烷基,三氟甲基,C1-4烷氧基 ,C 1-4烷基羰基氧基,二-C 1-4烷基氨基,C 1-4烷基磺酰氧基,C 1-4烷基磺酰基,C 1-4烷基亚磺酰基或C 1-4烷硫基,或R 3a和R 3b ,或R4a和R4b连接以代表亚烷基二氧基; X表示氧原子,硫原子或N-R5(其中,R5表示氢原子,C1-4烷基,C1-4烷基磺酰基或C1-4烷氧基羰基)。 Y表示氧原子,S(O)1基(l表示0〜2的数),羰基,羰基氨基,氨基羰基,磺酰基氨基,氨基磺酰基或NH基。 Z表示CH或N; n表示1〜6的数; m代表2至6的数,或其盐,他汀类,特别是匹伐他汀组合。